Mini review · 13 Feb 2026
Conference abstractPublished 17 Oct 2016
Radiation treatment of mediastinal lymphoma with method of the synchronization for breathing and dose evaluation in the heart
NRICP - Centre for Radiosurgery and Radiation Therapy, Novosibirsk, Russian Federation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cardiovascular diseases (CVD) and cancer are one of the leading causes of mortality in the world. Radiation therapy of the mediastinum is one of the cases of CVD. Over last 10 years of diagnostic and treatment methods have increased lifetime of the patients. Since, mediastinal lymphoma has positioning near the heart and radiation dose captures it, the risk is greatest in young patients (up to 40 years), who undergo radiotherapy and in the subsequent, they have mortality due to cardiac complications within first five years after the exposure. The interval between exposure and development of pathologists usually exceeds 7-10 years. Mediastinal lymphoma is Ã?¢Ã?Â?Ã?Â?mobile regionÃ?¢Ã?Â?Ã? and when the patient is breathing Ã?¢Ã?Â?Ã?Â?targetÃ?¢Ã?Â?Ã? is shifting. That is very important thing- breath (or movement of the chest wall), which can change Ã?¢Ã?Â?Ã?Â?target positionÃ?¢Ã?Â?Ã? about critical structures (heart, lungs, spinal cord, and esophagus). That is way, the procedure irradiating of mediastinal lymphoma without breathing control has high risk. Using radiotherapy treatment with breath-holding system, for example, Active Breathing Coordinator system- ABC, is advanced method. It can reduce radiation dose to the heart. We did research in our clinic and used ABC and Elekta Axesse linac for treatment of mediastinal lymphoma. We got very good results which were based on dose distribution to the heart, not more than 17 Gy, regardless from lymphoma positioning and size. It is very good indicator, exceptionally for patients with cardiac disease.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Hematology & Thromboembolic Diseases.
Opinion · 25 Dec 2025
Clinical Patterns and Systemic Implications of Thromboembolism
Opinion · 25 Dec 2025
Integrating Clinical Risk and Preventive Care in Thromboembolism Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Hematology & Thromboembolic Diseases
- SubjectHaematology
- BylineArticles whose byline prints “Lamanova Olesya Nikolaevna”
- BylineArticles whose byline prints “Filatova E V”
